1. Hitchins MP, Stanier P, Preece MA, Moore GE. Silver-Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions. J Med Genet 2001; 38: 810- 819.
2. Eggermann T, Gonzalez D, Spengler S, Arslan KM, Binder G, Schönherr N. Broad clinical spectrum in Silver-Russell syndrome and consequences for genetic testing in growth
retardation. Pediatrics 2009; 123: 929-931.
3. Wakeling EL, Amero SA, Alders M, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med
Genet 2010; 47: 760-768.
4. Price SM, Stanhope R, Garrett C, Preece MA, Trembath RC.
The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria. J Med
Genet 1999; 36: 837-842.
5. Wollmann HA, Kirchner T, Enders H, Preece MA. Ranke MB. Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients. Eur J Pediatr 1995; 154: 958-968.
6. Gucev ZS, Tasic V, Jancevska A, Kirovski I. A case of Silver-Russell syndrome (SRS): multiple pituitary hormone deficiency, lack of H19 hypomethylation and favourable growth hormone (GH) treatment response. J Genet 2009; 88:
239-243.
7. Lai KYC, Skuse D, Stanhope R, Hindmarsh P. Cognitive abilities associated with the Silver-Russell syndrome. Arch
Dis Child 1994; 71: 490-496.
8. Abu-Amero S, Monk D, Frost J, Preece M, Stanier P, Moore GE. The genetic etiology of Silver-Russell syndrome. J Med Genet 2008; 45: 193-199.
9. Schonherr N, Meyer E, Roos A, Schmidt A, Wollmann HA, Eggermann T. The centromeric 11p15 imprinting centre is also involved in Silver-Russell syndrome. J Med Genet 2007; 44:
59-63.
10. Eggermann T, Begemann M, Binder G, Spengler S. Silver-Russell syndrome: genetic basis and molecular genetic testing. Orphanet J Rare Dis 2010; 23: 5-19.
11. Binder G, Seidel AK, Martin DD, et al. The endocrine phenotype in silver-russell syndrome is defined by the underlying epigenetic alteration. J Clin Endocrinol Metab
2008; 93: 1402-1407.
12. Netchine I, Rossignol S, Dufourg MN, et al. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. J Clin
Endocrinol Metabol 2007; 92: 3148-3154.
13. Chatelain PG. Auxology and response to growth hormone treatment of patients with intrauterine growth retardation or Silver-Russell syndrome: analysis of data from the Kabi pharmacia international growth study. International board of the Kabi pharmacia international growth study. Acta Paediatr 1993; 82: 79-81.
14. Stanhope R, Albanese A, Azcona C. Growth hormone treatment of Russell-Silver syndrome. Acta Paediatr Scand Suppl 1989; 349: 35-41.
15. Rakover Y, Dietsch S, Ambler GR, Chock C, Thomsett M,
Cowell CT. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand growth database. Eur J Pediatr 1996; 155: 851-857.
16. Silver HK, Kiyasu W, George J, Deamer WC. Syndrome of congenital hemihypertrophy, shortness of stature, and elevated urinary gonadotrophins. Pediatrics 1953; 12: 368- 375.
17. Chitayat D, Friedman JM, Anderson L, Dimmick JE. Hepatocellular carcinoma in a child with familial Russell-Silver syndrome. Am J Med Genet 1988; 31: 909-914.
18. Dang YN, Shin IC, Gordon RA, Karcioglu ZA. Bilateral
reactive lymphoid hyperplasia of the orbit in a child with Russell-Silver syndrome. J AAPOS 2004; 8: 588-591.
19. Bliek J, Terhal P, Van den Bogaard MJ, et al.
Hypomethylation of the H19 gene causes not only Silver-Russell syndrome (SRS) but also isolated asymmetry or an SRS-like phenotype. Am J Hum Genet 2006; 78: 604-614.
20. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005; 37: 1003-1007.
Thank you for copying data from http://www.arastirmax.com
